TY - JOUR
T1 - Chemoembolization of hepatocellular carcinoma in patients who undergo liver transplantation
AU - Spreafico, Carlo
AU - Marchianò, Alfonso
AU - Regalia, Enrico
AU - Frigerio, Laura F.
AU - Garbagnati, Francesco
AU - Andreola, Salvatore
AU - Milella, Marco
AU - Lanocita, Rodolfo
AU - Mazzaferro, Vincenzo
PY - 1994/9
Y1 - 1994/9
N2 - PURPOSE: To determine the efficacy of chemoembolization (CHE) for hepatocellular carcinoma (HCC) in patients with a cirrhotic liver. MATERIALS AND METHODS: Twenty-one patients with cirrhosis and 33 HCC nodules received a mean of 2.4 cycles of CHE before orthotopic liver transplantation (OLT). Iodized oil plus doxorubicin (13 patients) or mitoxantrone (eight patients) was injected into the hepatic artery. Twelve (57%) of the patients underwent terminal embolization with gelatin sponge pledgets. After OLT, the percentage of tumor necrosis was assessed in each HCC nodule. RESULTS: Twelve (36%) of 33 HCC nodules responded completely to CHE (necrosis > 90%). Successful treatment was statistically significantly related to nodular diameter greater than 2 cm (P = .03), solitariness (P = .0009), hypervascularity (P = .001), and good retention of iodized oil (P = .05). Seven (33%) of the patients had major complications; no death occurred in association with CHE. All patients survived OLT; in three patients (14%), HCC recurred a median of 21 months after OLT. CONCLUSION: CHE seems to be an effective treatment for HCC in patients with liver cirrhosis who await OLT.
AB - PURPOSE: To determine the efficacy of chemoembolization (CHE) for hepatocellular carcinoma (HCC) in patients with a cirrhotic liver. MATERIALS AND METHODS: Twenty-one patients with cirrhosis and 33 HCC nodules received a mean of 2.4 cycles of CHE before orthotopic liver transplantation (OLT). Iodized oil plus doxorubicin (13 patients) or mitoxantrone (eight patients) was injected into the hepatic artery. Twelve (57%) of the patients underwent terminal embolization with gelatin sponge pledgets. After OLT, the percentage of tumor necrosis was assessed in each HCC nodule. RESULTS: Twelve (36%) of 33 HCC nodules responded completely to CHE (necrosis > 90%). Successful treatment was statistically significantly related to nodular diameter greater than 2 cm (P = .03), solitariness (P = .0009), hypervascularity (P = .001), and good retention of iodized oil (P = .05). Seven (33%) of the patients had major complications; no death occurred in association with CHE. All patients survived OLT; in three patients (14%), HCC recurred a median of 21 months after OLT. CONCLUSION: CHE seems to be an effective treatment for HCC in patients with liver cirrhosis who await OLT.
KW - Arteries, chemotherapeutic embolization
KW - Liver neoplasms, blood supply
KW - Liver, interventional procedure
UR - http://www.scopus.com/inward/record.url?scp=0027956899&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027956899&partnerID=8YFLogxK
M3 - Article
C2 - 8058934
AN - SCOPUS:0027956899
VL - 192
SP - 687
EP - 690
JO - Radiology
JF - Radiology
SN - 0033-8419
IS - 3
ER -